Patent Search and Filing

Barr confirms patent challenge of TEMODAR (News-Medical-Net)
Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed for Schering Corporation’s TEMODAR (Temozolomide) 5mg, 20mg, 100mg & 250mg capsules.

This entry was posted on Wednesday, July 25th, 2007 at 8:58 pm and is filed under Patents. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.